We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPRA:NASDAQOpera Limited Analysis

Data as of 2026-05-21 - not real-time

$17.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Opera’s stock is trading above its short‑term moving average while still below the longer‑term average, indicating a bullish bias despite a recent bearish MACD crossover and a neutral RSI that suggests limited near‑term momentum. The price is holding near a key support level with decreasing volume, and the high beta combined with elevated 30‑day volatility points to a swing‑y‑risk profile. Fundamentally, the company delivered a strong revenue surge of over twenty percent year‑over‑year, driven by AI‑enhanced browser offerings and expanding ad‑tech services, while maintaining solid gross and operating margins. At the same time, the forward‑looking P/E sits comfortably below the industry average and the dividend yield remains among the highest in the sector, supporting a value narrative.
The discounted cash‑flow model implies a valuation substantially above the current market price, translating into a sizable upside potential. However, the firm faces partnership uncertainty with major platform providers, which could temper growth expectations. Overall, the blend of growth drivers, attractive yield, and a deep discount to intrinsic value creates a compelling case for investors willing to navigate the heightened volatility and beta exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with decreasing volume
  • Bearish MACD histogram indicating short‑term pressure
  • High beta and volatility amplifying price swings

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and AI product rollout
  • Undervalued relative to DCF and industry multiples
  • Robust dividend yield providing cash return

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable cash flow and low debt profile
  • Continued expansion in ad‑tech and Web3 services
  • Significant upside to intrinsic value despite partnership risks

Key Metrics & Analysis

Financial Health

Revenue Growth23.20%
Profit Margin17.71%
P/E Ratio13.8
ROE11.97%
ROA5.76%
Debt/Equity0.90
P/B Ratio1.6
Op. Cash Flow$143.9M
Free Cash Flow$128.4M
Industry P/E17.1

Technical Analysis

TrendBullish
RSI50.6
Support$16.41
Resistance$19.24
MA 20$17.92
MA 50$16.24
MA 200$15.47
MACDBearish
VolumeDecreasing
Fear & Greed Index90.29

Valuation

Fair Value$48.47
Target Price$26.29
Upside/Downside50.72%
GradeUndervalued
TypeBlend
Dividend Yield4.59%

Risk Assessment

Beta1.53
Volatility41.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.